Nucleic Acid Testing (NAT) Market analysis report comprises of market data that can be relatively essential when it comes to dominate the market or make a mark in the market as a new emergent. The purpose of this market report is to provide a detailed analysis of pharmaceutical industry and its impact based on applications and on different geographical regions. This market research report is a resource for getting current as well as upcoming technical and financial details of the industry to 2030. It also strategically analyses the growth trends and future prospects. An influential Nucleic Acid Testing (NAT) Market report also lists down the leading competitors and provides the insights about the strategic industry analysis of the key factors influencing the pharmaceutical industry.
Request For Free Sample Report at: https://www.delvens.com/get-free-sample/nucleic-acid-testing-market
Nucleic Acid Testing Market, By Product Type (Nucleic Acid Test Kits (Polymerase Chain Reaction (PCR), Ligase Chain Reaction (LCR), Transcription–mediated Amplification (TMA), Whole Genome Sequencing) and Consumables), By Indication (Infectious Disease, Cancer, Forensic Testing, Personalized Medicine, and Others), By End User (Hospitals & Clinics, Pathology Laboratories, and Academic & Research Organization) and region (North America, Europe, Asia-Pacific, Middle East and Africa and South America). The global Nucleic Acid Testing (NAT) Market size is projected to reach a CAGR of 7.7% from 2023-2030.
Nucleic Acid Testing Market Competitive Landscape:
Abbott Laboratories
Beckman Coulter, Inc.
Becton
Dickinson and Company
BioMérieux SA
Bio-Rad Laboratories, Inc.
F. Hoffmann-La Roche Ltd.
Grifols S.A.
Illumina, Inc.
Novartis Ag
Qiagen N.V.
Quest Diagnostics Incorporated
Siemens Ag
Tecan Group Ltd
Danaher
Thermo Fisher Scientific Inc.
Johnson & Johnson Services Inc.
Nucleic Acid Testing Market Recent Developments:
In December 2021, Roche, a multinational healthcare company based in Switzerland, introduced its latest infectious disease tests on a novel molecular laboratory instrument named cobas 5800 System in countries accepting the CE mark.
11 April 2022 — Abbott, the global healthcare leader, has launched Arachitol Gummies in India, a new fruit-flavoured product for kids and adults. Arachitol Gummies are a dietary supplement that helps maintain required levels of Vitamin D sustainably. As the body needs vitamin D to absorb calcium for better bone health, keeping recommended levels of vitamin D is essential for overall well-being.
Make an Inquiry Before Buying at: https://www.delvens.com/Inquire-before-buying/nucleic-acid-testing-market
Nucleic acid testing (NAT) refers to a molecular technique for screening viruses, bacteria or pathogenic nucleic acid in the blood, tissue or urine of the patient. It is conducted for forensic testing and to diagnose transfusion-transmitted infections, genetic diseases and cancer. It involves sample pooling through nucleic acid (NA) extraction, target NA amplification and target amplicon NA detection. The testing involves kits and consumables for performing polymerase chain reaction (PCR), strand displacement amplification (SDA), ligase chain reaction (LCR), transcription-mediated amplification (TMA) and NA sequence-based amplification (NASBA) processes. NAT is also used for the identification of diseases with no visible symptoms and for resolving false reactive interpretations.
Rising usage of nucleic acid tests for the treatment of genetically related diseases, cancerous diseases, and infectious diseases caused by bacteria or viruses is anticipated to spur their demand worldwide. Apart from this, extensive use utilized for paternity testing/HLA typing and forensic testing will aid the expansion of the nucleic acid testing market in the coming years. These tests help healthcare professionals and researchers in narrowing down the period of infection. In other words, it reduces the window period between the time of serological detection of a virus and the time of viral exposure. Thus, the ability of these tests to deliver accurate results in the early detection process is likely to accelerate their demand in the forthcoming years.
The inability or difficulty of nucleic acid testing in obtaining quantitative results from a large pool of clinical sample, the difficulty of using the NAT test for susceptibility testing, and the higher cost of nucleic acid testing devices is expected to hamper the growth of the nucleic acid testing market. NAT is a highly sensitive and advanced technique; however, it is associated with high cost and requires dedicated infrastructure facility, equipment, consumables, and technical expertise thus these factors are also hindering the growth of the market.
Scope of the Nucleic Acid Testing (NAT) Market Report:
Nucleic Acid Testing (NAT) Market is segmented into various segments such as product type, indication, end user and region:
On the basis of product type
Nucleic Acid Test Kits
Consumables
On the basis of the indication
Infectious Disease
Cancer
Forensic Testing
Personalized Medicine
Others
On the basis of end-use
Hospitals & Clinics
Pathology Laboratories
Academic & Research Organization
On the basis of region
Asia Pacific
North America
Europe
South America
Middle East & Africa
Nucleic Acid Testing (NAT) Market Regional Analysis:
North America to Dominate the Market
North America holds a dominant position in the nucleic acid testing market. This is owing to increasing research and development studies by various government and pharmaceutical organizations in infectious disease and cancer diagnosis in North America.
Furthermore, high prevalence and awareness of cancer among people, in turn opting for early detection of cancer, is expected to aid in the growth of the nucleic acid testing market in this region.
Direct Purchase of the Nucleic Acid Testing (NAT) Market Research Report at: https://www.delvens.com/checkout/nucleic-acid-testing-market
Browse Related Reports:
Plastic Surgery and Integumentary System Market
Antibody Drug Conjugates (ADC) Market
About Us:
Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally.
Delvens database assists the clients by providing in-depth information in crucial business decisions. Delvens offers significant facts and figures across various industries namely Healthcare, IT & Telecom, Chemicals & Materials, Semiconductor & Electronics, Energy, Pharmaceutical, Consumer Goods & Services, Food & Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.
Contact Us:
UNIT NO. 2126, TOWER B,
21ST FLOOR ALPHATHUM
SECTOR 90 NOIDA 201305, IN
+44-20-3290-6466
A new research report by Future Market Insights on the global nucleic acid testing market reveals has been titled, ‘Nucleic Acid Testing Market – Global Industry Analysis 2012 – 2016 and Opportunity Assessment 2017 – 2027,’ and assesses the growth prospects of the nucleic acid testing market for the next nine years.
The report also comprises preferences of patients and doctors across the globe, which helps in accessing the current as well as future demand of the nucleic acid testing market.
It may lead to an increase in healthcare costs, with the promise that quality of care will go up.Download Sample Copy@ https://www.futuremarketinsights.com/reports/sample/rep-gb-1106The healthcare system is in a phase where access to capital is constantly diminishing.
Healthcare institutions are either postponing large capital-intensive projects or allocating resources to specialty areas that offer a high ROI.
Providers and insurers are strategizing to tap into the available opportunities in this demographic.
Baby boomers around the globe are actively taking charge of their health.
